Stream Biomeical is a biotechnology company - currently resident in JLab Houston - structured around addressing the unmet therapeutic needs for individuals suffering from neurologic trauma or degeneration. The firm is employing a recombinant therapeutic protein that has previously proven to be neuroprotective and neuroreparative. Pre-clinical.experience suggests that, when administered after neurologic insult, the product can provide functional improvement potentially enabling patients suffering from stroke, traumatic brain injury, spinal cord injury, Alzheimer's, vascular dementia, Parkinson's and other neurologic conditions to achieve some level of functional recovery. In the JLab context, the initial target therapeutic application is for the treatment of acute stroke. Later targets will include traumatic brain injury (TBI) and Alzheimers/dementia.
